Continuing%20Medical%20Education%20and%20Industry%20Sponsorship - PowerPoint PPT Presentation

About This Presentation
Title:

Continuing%20Medical%20Education%20and%20Industry%20Sponsorship

Description:

Fair market value payments for reasonable, necessary, legitimate services ... Additional information is available on our website at http://oig.hhs.gov ... – PowerPoint PPT presentation

Number of Views:44
Avg rating:3.0/5.0
Slides: 13
Provided by: oig18
Category:

less

Transcript and Presenter's Notes

Title: Continuing%20Medical%20Education%20and%20Industry%20Sponsorship


1
Continuing Medical Education and Industry
Sponsorship
  • The Pharma, Biotech and Device
  • Colloquium
  • Princeton, NJ
  • June 7, 2005
  • Julie K. Taitsman, M.D., J.D.
  • Senior Counsel
  • Industry Guidance Branch
  • Office of Counsel to the Inspector General

2
The Anti-Kickback Statute
  • Section 1128B(b) of the Social Security Act
  • Criminal statute
  • Prohibits purposeful payments, made directly or
    indirectly, to induce or reward the referral of
    items or services payable by Federal health care
    programs

3
The Anti-Kickback Statute
  • Remuneration
  • Offered, paid, solicited, or received
  • To induce or reward Federal business
  • Knowingly and willfully

4
The Anti-Kickback Statute
  • Arranging for or recommending
  • One purpose test
  • Penalties
  • Criminal
  • Civil
  • Administrative

5
Why Kickbacks Harm the Health Care System
  • Overutilization
  • Increased program cost
  • Improper steering
  • Unfair competition
  • Systemic corruption

6
Ways Industry Sponsors Educational Activities
  • Industry-run programs
  • Grants to for-profit CME providers
  • Grants to academic institutions
  • Grants to professional organizations

7
Types of Kickbacks
  • From drug or device manufacturer
  • to CME provider
  • directly to physician
  • indirectly to physician

8
OIGs CPG for Pharmaceutical Manufacturers CME
Risk Areas
  • Funding based on referral levels
  • Sham education projects
  • Funding conditioned on content or faculty of an
    educational program
  • Manufacturer influence over the presenter of an
    educational program
  • Violation of FDA rules

9
CPG Recommendations
  • Separate grant making functions from sales and
    marketing
  • Establish objective criteria that do not take
    into account the volume or value of referrals
  • No manufacturer control over the speaker or
    content of the educational activity
  • Bona fide educational purpose
  • Documentation and regular monitoring

10
OIGs CPG for Pharmaceutical Manufacturers
Consultants Risk Areas
  • Sham consulting arrangements
  • Payments for physicians to attend conferences in
    a passive capacity
  • Payments for promotional activities
  • Ghost written papers or speeches
  • Gifts and gratuities

11
Consultants Recommendations
  • Fair market value payments for reasonable,
    necessary, legitimate services
  • Safe harbor whenever possible
  • Disclose potential conflicts of interest
  • Documentation

12
Conclusion
  • Educational activities are important
  • Funding must be accomplished in a fashion that is
    free from fraud and abuse
  • Additional information is available on our
    website at http//oig.hhs.gov
Write a Comment
User Comments (0)
About PowerShow.com